AI assistant
CONMED Corp — Director's Dealing 2020
Dec 1, 2020
31971_dirs_2020-11-30_d8c5afff-569e-4ffe-bba2-b7d920e8c1e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-11-25
Reporting Person: Hartman Curt R (Director, President, CEO and Chair)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-25 | Common Stock | M | 136000 | $39.87 | Acquired | 240051 | Direct |
| 2020-11-25 | Common Stock | F | 92194 | $106.14 | Disposed | 147857 | Direct |
| 2020-11-25 | Common Stock | S | 2512 | $105.4011 | Disposed | 145345 | Direct |
| 2020-11-27 | Common Stock | S | 596 | $105.0117 | Disposed | 144749 | Direct |
| 2020-11-30 | Common Stock | S | 5192 | $101.6893 | Disposed | 139557 | Direct |
| 2020-11-30 | Common Stock | S | 1700 | $102.7424 | Disposed | 137857 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-25 | Options To Purchase Common Stock | $39.87 | M | 136000 | Disposed | 2026-03-01 | Common Stock (136000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.84 to $105.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.34 to $102.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.355 to $103.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.